EzySpot

Similar stories

Worldwide Blood Glucose Device Market 5 years 46 weeks ago

Self-Monitoring Blood Glucose (SMBG) device market is primary dependent on diabetes population. In 2015, as per International Diabetes Federation, one in 11 adults has been suffering from diabetes and this trend is forecasted to increase to one in 10 adults by 2040. It shows that diabetes prevalence is continuously growing which help to boost the SMBG device market globally. Our research report “Blood Glucose Device Market & Forecast (SMBG) (Test Strips, Lancet, Meter) – Worldwide Analysis” provide details on following points:
• Diabetes Population Numbers (Type 1 and Type 2 Diabetes) & Forecast
• Self-Monitoring Blood Glucose (SMBG) Devices Users & Forecast
• Self-Monitoring Blood Glucose Devices (SMBG) Market (Test Strips, Lancet, Glucose Meter) & Forecast

United States – Insulin Pump Users Market & Forecast 5 years 32 weeks ago

USA insulin pump market is expected to grow more than US$ 5 Billion by the end of year 2022. The convenience of using insulin pump are gaining inclusive acceptance in the market as insulin delivery systems. Now insulin Pump has become famous and a preferred device for Type1 diabetes patients in the United States. Insulin Pump market constitutes comparatively small portion of total Insulin Delivery Systems market.

Diabetes Drug Market Outlook 4 years 8 weeks ago

Diabetes is a health disorder in which the level of blood glucose gets elevated in the human body. Global Diabetes Drugs Market is projected to go beyond US$ 76 Billion by the end of the year 2024. Type 1 Diabetes: Type 1 diabetes also known by the name of juvenile or childhood-onset or insulin-dependent diabetes is characterized by the deficient insulin production and needs insulin administration daily. Type 2 Diabetes: Type 2 diabetes formerly known as adult-onset or non-insulin dependent diabetes results from the human body’s ineffective use of insulin.

US Insulin Pump Market & Forecast 5 years 30 weeks ago

US insulin pump market is projected to cross US$ 5 Billion by end of the year 2022. A medical device which is used for the management of insulin in the treatment of diabetes is called “Insulin Pump”. Insulin Pump is a small programme device similar to mobile phone. It is very convenient to use, as this can be easily carried out. The device contains buttons to program insulin and navigates through the menu.

Global Insulin Market Research Report 2018-2022 5 years 4 weeks ago

Insulin Market: Insulin is an anabolic hormone secreted by β-cells of pancreatic islets. Insulin helps in the metabolism of carbohydrates, proteins, and fats by absorbing the glucose and converts to glycogen by glycogenesis and stores in the skeletal muscles. Deficiency of insulin leads to the hyperglycemia or diabetes mellitus. Insulin is commonly used in type-1 diabetes, however, rarely used in the type 2 diabetes. The β-cells of the pancreas are destroyed due to the autoimmune reaction and causes insulin deficiency which leads to type-1 diabetes. In type 2 diabetes, the body becomes more resistant to insulin and requires more insulin for the carbohydrate metabolism.

United States Insulin Delivery Device Market – Enabling Self-Care for Diabetic Patients 1 year 17 weeks ago

The United States insulin delivery devices market is one of the highest evolving industries with potential opportunities throughout 2027. The report on the medical device market research delivers an all-around analysis of the overall number of patients with diabetes in the United States. Moreover, the report provides deep insights on type 1, type 2, and newly diagnosed type 1 diabetes patients’ data.

United States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 - 2020 and Industry Forecast 2021 - 2027 2 years 5 weeks ago

The United States Self-Monitoring Blood Glucose Market is anticipated to cross US$ 4.6 billion by the year-end of 2027. Large patient pool suffering from diabetes, the rapid uptake of innovative, user-friendly, and technological advancements products, the surge in the aging population, and an upsurge in risk factors that lead to diabetes drive the growth of the U.S self-monitoring blood glucose market.